Expression of TGF-β1, -β2 and -β3 in localized and systemic scleroderma
- 1 September 1999
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 21 (1) , 13-22
- https://doi.org/10.1016/s0923-1811(99)00008-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A brief overview of the pathogenesis of scleroderma (systemic sclerosis).Annals of the Rheumatic Diseases, 1992
- Transforming growth factor-β1 induces extracellular matrix formation in glomerulonephritisCell Differentiation and Development, 1990
- Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.Journal of Clinical Investigation, 1990
- Evaluation of Transforming Growth Factor β and Type I Procollagen Gene Expression in Fibrotic Skin Disease by In Situ HybridizationJournal of Investigative Dermatology, 1990
- Transcription and Expression of Transforming Growth Factor Type Beta in the Skin of Progressive Systemic Sclerosis: A Mediator of Fibrosis?Journal of Investigative Dermatology, 1990
- In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.The Journal of cell biology, 1989
- Systemic scleroderma: Clinical and pathophysiologic aspectsJournal of the American Academy of Dermatology, 1988
- Localization of collagen mRNA in normal and scleroderma skin by in‐situ hybridizationEuropean Journal of Clinical Investigation, 1988
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- THE PATHOPHYSIOLOGY OF SCLERODERMAInternational Journal of Dermatology, 1977